1Machold KP,Stamm TA,Eberl GJ,et al.Very recent onset arthritis--clinical,laboratory,and radiological findings during the first year of disease[J].Rheumatol,2002,29(11):2 278-2 287.
2Symmons DP,Hazes JM,Silman AJ.Cases of early inflammatory polyarthritis should not be classified as having rheumatoid arthritis[J].J Rheumatol,2003,30(5):902-904.
3Raza K,Breese M,Nightingale P,et al.Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis[J].J Rheumatol,2005,32(2):231-238.
6Schellekens GA, de Jong BA, van den Hoogen FH, et al.Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis - specific autoantibodies [J]. J Clin Invest,1998,101(1):273-281.
7van Gaalen FA, Linn- Rasker SP, van Venrooij WJ, et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study [J ]. Arthritis Rheum, 2004,50(3) :709 - 715.
8Schellekens CA, Visser H, de Jong BA, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide [ J ]. Arthritis Rheum, 2000,43 (1) :155 - 163.
9Lee AN, Beck CE, Hall M, et al. Rheumatoid factor and anti- CCP autoantibodies in rheumatoid arthritis: a review [J]. Clin Lab Sci,2008,21(1):15- 18.
10Kroot EJ, de Jong BA, van Leeuwen MA, et al. The prognostic value of anti - cyclic citrullinated peptide antibody in patients with recent- onset rheumatoid arthritis [J]. Arthritis Rheum,2000,43(8) : 1831 - 1835.
